Orange Book product · Generic (ANDA)
MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
At a glance
May 04, 2009
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 04, 2009
17 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
MYCOPHENOLATE MOFETIL
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 065433
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MYCOPHENOLATE MOFETIL
- 2024MYHIBBINBrand (NDA)
NDA 216482 · AZURITY
- 1998CELLCEPTBrand (NDA)
NDA 050759 · ROCHE PALO
- 1997CELLCEPTBrand (NDA)
NDA 050723 · ROCHE PALO
- 1995CELLCEPTBrand (NDA)
NDA 050722 · ROCHE PALO
- 2026MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 218566 · CONCORD BIOTECH LTD
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 214079 · WUXI
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 207022 · HETERO LABS LTD V
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 208119 · HETERO LABS LTD V
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 218227 · AUROBINDO PHARMA LTD
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 217937 · AUROBINDO PHARMA
- 2024MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 217828 · AUROBINDO PHARMA LTD
- 2023MYCOPHENOLATE MOFETILGeneric (ANDA)
ANDA 213955 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

